Instead, combined Sik1/2 deletion leads to higher BP but does not alter LVH on chronic HS intake, suggesting that SIK1 is required for maintaining normal BP while SIK2 is required for HS-induced cardiac hypertrophy independent of high BP (Pires et al., 2021). Here, SIK2 is linked to cardiac hypertrophy.